What Proscar is approved for
Finasteride 5 mg is approved for symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. BPH is a non-cancerous growth of the prostate that squeezes the urethra and causes a weak stream, frequent urination and trouble emptying the bladder. The label lists three goals: improve symptoms, reduce the risk of acute urinary retention (a sudden inability to urinate), and reduce the need for surgery. Proscar is also approved in combination with the alpha-blocker doxazosin to reduce the risk of symptoms getting worse. It is not approved to prevent prostate cancer.
The drug works by lowering DHT, the hormone that drives prostate growth, which shrinks the gland over time. This is the same action that helps hair at a fifth of the dose (see dosage and how it works).
What the PLESS trial showed
PLESS showed that four years of finasteride halved the risk of the two most serious BPH events. The trial randomized 3,040 men with moderate to severe symptoms and enlarged prostates to finasteride 5 mg or placebo.
| Outcome over four years | Finasteride 5 mg | Placebo |
|---|---|---|
| Surgery for BPH | 5% | 10% |
| Acute urinary retention | 3% | 7% |
| Average drop in symptom score (34-point scale) | 3.3 points | 1.3 points |
| Change in prostate volume | Down 17.9% | Up 14.1% |
That works out to a 55% lower risk of surgery and a 57% lower risk of urinary retention. Symptom relief is slower than with some other prostate drugs: the label says a trial of at least six months is generally needed to judge whether it is helping.
MTOPS: finasteride with doxazosin
MTOPS found that finasteride plus doxazosin worked better than either drug alone at stopping BPH from progressing. The trial followed 3,047 men for an average of 4.5 years on placebo, doxazosin, finasteride, or both. Compared with placebo, the risk of overall clinical progression fell by 39% with doxazosin, 34% with finasteride, and 66% with the combination. Finasteride and the combination also lowered the risk of acute urinary retention and of invasive treatment. Doxazosin alone did not. Alpha-blockers such as doxazosin relax the muscle around the urethra and work quickly, while finasteride shrinks the gland slowly, so the two complement each other.
PSA halving and side effects at 5 mg
Finasteride 5 mg cuts PSA roughly in half, and this has to be accounted for in prostate cancer screening. PSA (prostate-specific antigen) is a blood marker used to screen for prostate cancer. The Proscar label says PSA falls by about 50% within six months, that a new baseline should be set after six months of treatment, and that a single reading in a man treated for six months or more should be doubled before comparing it with normal ranges. Any confirmed rise from the lowest value on treatment should be evaluated.
Tell whoever orders your PSA test that you take finasteride. An unadjusted result can look falsely reassuring.
Sexual side effects were more common at this dose and in this older age group than in the hair loss trials. In the first year of PLESS, impotence was reported as drug related by 8.1% of men on finasteride and 3.7% on placebo, decreased libido by 6.4% and 3.4%, and decreased ejaculate volume by 3.7% and 0.8%. In years two to four there was no significant difference between the groups for impotence, decreased libido or ejaculation disorder. The label also carries a warning about high-grade prostate cancer from a separate prevention trial, explained on the long-term safety page. The studies page summarizes each trial.
Common questions
How long does finasteride take to work for BPH?
The label says at least six months is generally needed to assess symptom relief. Urinary flow in PLESS was already better than placebo by month 4.
Is Proscar the same drug as Propecia?
Yes. Both are finasteride. Proscar is 5 mg for the prostate and Propecia is 1 mg for male pattern hair loss.
Will 5 mg finasteride for BPH also help my hair?
It lowers DHT at least as much as 1 mg, and dose-ranging hair trials found 5 mg and 1 mg had similar effects on hair. It is not approved or labeled for hair loss at that dose.
Does finasteride prevent prostate cancer?
It is not approved for that. A large prevention trial found fewer cancers overall but more high-grade ones, which led to a label warning.
Sources
- Organon. Proscar (finasteride) tablets 5 mg, full prescribing information. DailyMed, National Library of Medicine. DailyMed: Proscar label
- McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. New England Journal of Medicine, 1998. PubMed 9475762
- McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. New England Journal of Medicine, 2003. PubMed 14681504
- Roberts JL, Fiedler V, Imperato-McGinley J, et al. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. Journal of the American Academy of Dermatology, 1999. PubMed 10495375